Transdigm Group INC Form 4 insider transactions

Director Michael Graff of TransDigm Group INC reported the disposal of 200 common stock shares, alongside holdings through his wife and trusts.

TransDigm Group director Gary E. McCullough acquired 450 stock options on October 31, 2024, which vest based on performance targets between fiscal years 2025 and 2029.

TransDigm Group director Sean P. Hennessy acquired 450 stock options on October 31, 2024, which vest based on performance targets between fiscal years 2025 and 2029.

Robert J. Small, a director at TransDigm Group, acquired 450 stock options on October 31, 2024, which vest based on performance targets between fiscal years 2025 and 2029.

Michele Santana, a director at TransDigm Group, acquired 450 stock options on October 31, 2024, which vest based on performance targets between fiscal years 2025 and 2029.

Director Jorge L. Valladares III acquired 450 stock options in TransDigm Group INC on October 31, 2024.

A TransDigm Group director, David Barr, acquired 450 stock options on October 31, 2024, which vest based on performance targets between fiscal years 2025 and 2029.

Director Jane M. Cronin acquired 450 stock options in TransDigm Group, exercisable starting September 30, 2025, based on performance targets.

A TransDigm Group director, Michael Graff, acquired 450 stock options on October 31, 2024, which vest based on future performance targets.

Jessica L. Warren, General Counsel, Chief Compliance Officer, and Secretary of TransDigm Group, acquired 7,900 stock options on October 31, 2024.

TransDigm Group's Chief Financial Officer, Sarah Wynne, acquired 8,200 stock options on October 31, 2024, which vest based on future performance targets.

Michael Lisman, Co-Chief Operating Officer of TransDigm Group, acquired 9,850 stock options on October 31, 2024.

TransDigm Group's Co-Chief Operating Officer, Joel Reiss, exercised stock options and sold a portion of his holdings on November 20, 2024.

TransDigm Group's CEO, Kevin M. Stein, acquired 38,900 stock options on October 31, 2024, which vest based on the company's fiscal 2029 performance.

TransDigm Group director W. Nicholas Howley exercised stock options and sold a portion of his holdings on November 15, 2024.

Joel Reiss, Co-Chief Operating Officer of TransDigm Group INC, reports the exercise of stock options and subsequent sale of shares on October 15, 2024.

Director W. Nicholas Howley exercised stock options and sold shares of TransDigm Group INC on October 15, 2024, according to a Form 4 filing.

Jane M. Cronin, a director at TransDigm Group INC, acquired 27 shares of common stock on September 25, 2024, in lieu of a semi-annual director fee.

Director Jorge Valladares acquired 27 shares of TransDigm Group INC common stock in lieu of a semi-annual director fee.

Director Michael Graff acquired 27 shares of TransDigm Group INC common stock in lieu of semi-annual director fees on September 25, 2024.

Director Sean P. Hennessy reports changes in beneficial ownership of TransDigm Group INC stock, including acquisitions via director share plan.

Director David Barr acquired 34 shares of TransDigm Group INC common stock on September 25, 2024, in lieu of a semi-annual director fee.

Director Robert Small acquired 42 shares of TransDigm Group INC common stock in lieu of semi-annual director fees.

Michele Santana, a director at TransDigm Group INC, acquired 27 shares of common stock on September 25, 2024, in lieu of a semi-annual director fee.

Joel Reiss, Co-Chief Operating Officer of TransDigm Group INC, exercised stock options and sold shares on September 16, 2024, according to a Form 4 filing with the SEC.

Director Jorge Valladares reports the grant of stock options in TransDigm Group INC on September 17, 2024.

Director W. Nicholas Howley exercised stock options and sold shares of TransDigm Group INC on September 16, 2024, according to a Form 4 filing with the SEC.

Director Robert J. Small reports a transfer of TransDigm Group shares to members of Berkshire Partners LLC.

Joel Reiss, Co-Chief Operating Officer of TransDigm Group INC, exercised stock options and sold shares on August 15, 2024, according to a Form 4 filing with the SEC.

W. Nicholas Howley, a director at TransDigm Group INC, exercised stock options and sold shares on August 15, 2024, according to a recent SEC Form 4 filing.